Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 12, 2023

BUY
$4.2 - $6.01 $6.73 Million - $9.63 Million
1,601,574 Added 32.46%
6,535,674 $27.4 Million
Q4 2022

Feb 14, 2023

SELL
$4.45 - $6.17 $3.27 Million - $4.54 Million
-735,288 Reduced 12.97%
4,934,100 $29.7 Million
Q3 2022

Nov 10, 2022

BUY
$5.36 - $7.43 $10.7 Million - $14.8 Million
1,988,193 Added 54.01%
5,669,388 $33 Million
Q2 2022

Aug 12, 2022

SELL
$3.55 - $6.27 $3.56 Million - $6.29 Million
-1,003,209 Reduced 21.42%
3,681,195 $22 Million
Q1 2022

May 16, 2022

SELL
$1.9 - $5.23 $7.82 Million - $21.5 Million
-4,115,954 Reduced 46.77%
4,684,404 $21.9 Million
Q4 2021

Feb 14, 2022

BUY
$1.44 - $2.86 $1.2 Million - $2.39 Million
836,029 Added 10.5%
8,800,358 $21.8 Million
Q3 2021

Nov 12, 2021

BUY
$2.25 - $3.18 $746,547 - $1.06 Million
331,799 Added 4.35%
7,964,329 $23.5 Million
Q2 2021

Aug 16, 2021

BUY
$2.16 - $2.62 $9.37 Million - $11.4 Million
4,339,111 Added 131.75%
7,632,530 $19.1 Million
Q1 2021

May 14, 2021

BUY
$2.68 - $3.8 $3.32 Million - $4.71 Million
1,239,419 Added 60.34%
3,293,419 $9.58 Million
Q4 2020

Feb 12, 2021

SELL
$2.48 - $3.8 $4.25 Million - $6.52 Million
-1,714,597 Reduced 45.5%
2,054,000 $6.61 Million
Q3 2020

Nov 13, 2020

SELL
$1.02 - $2.15 $305,585 - $644,127
-299,594 Reduced 7.36%
3,768,597 $8.1 Million
Q2 2020

Aug 13, 2020

SELL
$0.88 - $1.32 $2.08 Million - $3.12 Million
-2,362,446 Reduced 36.74%
4,068,191 $4.72 Million
Q1 2020

May 14, 2020

BUY
$0.69 - $1.54 $1.85 Million - $4.12 Million
2,675,637 Added 71.26%
6,430,637 $5.92 Million
Q4 2019

Feb 13, 2020

BUY
$0.72 - $1.64 $30,960 - $70,521
43,001 Added 1.16%
3,755,000 $5.93 Million
Q3 2019

Nov 13, 2019

SELL
$0.64 - $0.92 $123,136 - $177,008
-192,401 Reduced 4.93%
3,711,999 $3.11 Million
Q2 2019

Aug 13, 2019

SELL
$0.8 - $1.03 $76,480 - $98,468
-95,600 Reduced 2.39%
3,904,400 $3.36 Million
Q1 2019

May 14, 2019

SELL
$0.9 - $1.37 $1.55 Million - $2.37 Million
-1,726,579 Reduced 30.15%
4,000,000 $3.88 Million
Q4 2018

Feb 13, 2019

BUY
$0.73 - $2.19 $309,896 - $929,690
424,516 Added 8.01%
5,726,579 $4.2 Million
Q3 2018

Nov 28, 2018

BUY
$1.72 - $5.24 $1.99 Million - $6.06 Million
1,156,604 Added 27.9%
5,302,063 $11.5 Million
Q3 2018

Nov 13, 2018

BUY
$1.72 - $5.24 $165,396 - $503,883
96,161 Added 2.37%
4,145,459 $8.95 Million
Q2 2018

Aug 14, 2018

SELL
$3.81 - $5.26 $4.16 Million - $5.75 Million
-1,092,448 Reduced 21.25%
4,049,298 $20.2 Million
Q1 2018

May 14, 2018

BUY
$2.7 - $4.06 $8.93 Million - $13.4 Million
3,306,908 Added 180.23%
5,141,746 $20.1 Million
Q4 2017

Feb 13, 2018

BUY
$2.47 - $3.34 $2.08 Million - $2.81 Million
841,838 Added 84.78%
1,834,838 $4.92 Million
Q3 2017

Nov 13, 2017

SELL
$3.12 - $3.65 $4.03 Million - $4.71 Million
-1,291,381 Reduced 56.53%
993,000 $3.17 Million
Q2 2017

Aug 14, 2017

BUY
N/A
2,284,381
2,284,381 $7.56 Million

About CTI BIOPHARMA CORP


  • Ticker CTIC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 114,385,000
  • Market Cap $1.04B
  • Description
  • CTI BioPharma Corp., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States. It offers VONJO (pacritinib), an investigational oral kinase inhibitor with specificity for JAK2, FLT3, IRAK1, and CSF1R for the treatment of adult patients w...
More about CTIC
Track This Portfolio

Track Stonepine Capital Management, LLC Portfolio

Follow Stonepine Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stonepine Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Stonepine Capital Management, LLC with notifications on news.